drugset / Trial / NCT00634140

The Influence of Ezetimibe on Gallbladder Function

NCT00634140

Withdrawn Indiana University
RandomizedParallel-groupDouble-blindBasic science

Summary

Ezetimibe is a drug which inhibits the absorption of both dietary and biliary cholesterol in the small intestine. Ezetimibe has been approved for use in humans to lower serum cholesterol. The primary aim of this study is to determine if ezetimibe normalizes resting and residual volume in patients with chronic acalculous cholecystitis.

Timeline

Start
2009-08
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg